ARLEKIN & MART Foundation 
in association with Jadow Productions
present

THE MERCHANT OF VENICE

written by WILLIAM SHAKESPEARE
adapted & directed by IGOR GOLYAK

Featuring Richard Topol as Shylock, Gus Birney, José Espinosa, Tess Goldwyn, Stephen Ochsner, Alexandra Silber

November 22-December 22, 2024

Run time: 2 hours 50 min including intermission

The Merchant of Venice is one of two productions presented by MART Foundation
as part of ARLEKIN IN RESIDENCE AT CLASSIC STAGE COMPANY

Click here for information and tickets to Our Class.

The most excellent historie of the Merchant of Venice 
with the exxtreame cruelitie of Shylocke the Jewe

This highly entertaining adaptation of Shakespeare’s The Merchant of Venice, directed by Ukrainian-born, Jewish theater artist Igor Golyak, is a wild ride that takes a startling and tragic turn, leaving the audience stunned and unable to stop the inevitable and unbearable consequences. Starring Richard Topol as Shylock with a stellar ensemble cast, this is Shakespeare for our time — a full force experience, urgent, deeply human, and full of questions.

“This production is a dead-serious indictment of antisemitism and bigotry from a dizzyingly kaleidoscopic array of angles.” – The Boston Globe

CREDITS
Scenic & Costume Design Nastya Bugaeva
Production Stage Manager Kyra Bowie
Associate Producer/Associate General Manager Anastasia Gudkova
General Management Martin Platt, Perry Street Theatricals
Executive Producer Sara Stackhouse

Classic Stage Company is a mask-optional space, and proof of vaccination is no longer required. All patrons attending performances and events are encourages but not required to wear masks. There will designated mask-required performances during each show run this season. 

We ask all audience members to please stay home if they have a sore throat, are feeling sick in any other way, or have been recently exposed to COVID-19. Please contact our box office for refunds or exchanges by calling 212.677.4210 x 10 or emailing [email protected]

CSC reserves the right to revise protocols as the rate of transmission changes and in light of new scientific data that may present itself.

Scroll to Top